ACP-105 SARMS Powder CAS 899821-23-9
ACP-105 is another non-steroidal Selective Androgen Receptor Modulator (SARM). Acadia proposes that ACP-105 is as potent as Testosterone in in vitro assays without interaction at other hormone receptors. In addition, ACP-105 demonstrates potent anabolic effects on muscle and bone with minimal effect on prostrate in preclinical models (hence it being a genuine SARM).
Anabolism - promotion and growth of lean muscle tissue and mass. This is extremely important for the individual suffering from a muscle wasting disease. It is the muscle wasting that at times can lead to the demise of the patient even before the disease itself.
The studies done on ACP-105 suggest that the human equivalent for the study using 1 mg/kg per day for a man weighing about 175 pounds would be about 11 mg per day.
Obviously equating this to some efficacious dosage where there would be minimal/no side effects for human use is impossible to do without some sort of experimentation being done, and as of now there are no clinical trials done on humans.
The consensus seems to suggest that a reasonable starting dosage is around 11-12mg per day for human research trials.read more